Sign in to view content

Risk Factors for Diabetic Retinopathy Progression During Pregnancy

Majda Hadziahmetovic, MD

Video
Published 2025

Related

Switching to Combination OPT-302 With Aflibercept From Prior Anti-VEGF-A Monotherapy in Eyes With Persistent Diabetic Macula Edema (DME)
David S. Boyer, MD
Annual Meeting Talks
2020
Aflibercept Monotherapy vs Initial Bevacizumab Followed by Aflibercept if Needed for Treatment of Center-Involved Diabetic Macular Edema
Chirag D. Jhaveri, MD, FASRS
Updates from the Field
2022
Interim 12-Month Results from PALADIN in Diabetic Macular Patients Receiving ILUVIEN: Analysis of the Prior Dexamethasone Cohort
Daniel F. Kiernan, MD, FACS
On Demand Cases, Courses, and Papers
2019

Category: Diabetic Retinopathy

See more